Food and Drug Administration approved the first GLP-1 drug for type 2 diabetes in 2005 and another, the first for weight loss, in 2014
Some develop or persist over time, making education and monitoring vital for long-term success
This combination of effects on appetite, digestion, and blood sugar helps create a calorie deficit that leads to weight loss over time
It is studied in laboratory research settings for its relationship to cellular signaling, pineal peptide research, and aging-related biological pathway studies
The number of sessions required for optimal skin brightening results will depend on the patients goals and physician recommendations
GLP-1 medications offer meaningful benefits, from significant weight loss to improved blood sugar and cardiovascular health